GLOBUS MEDICAL INC (GMED) is a publicly traded Healthcare sector company. As of May 20, 2026, GMED trades at $84.53 with a market cap of $10.71B and a P/E ratio of 110.28. GMED moved +5.14% today. Year to date, GMED is -7.12%; over the trailing twelve months it is +36.41%. Its 52-week range spans $51.79 to $101.40. Analyst consensus is strong buy with an average price target of $110.90. Rallies surfaces GMED's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
GLOBUS MEDICAL INC (GMED) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. GMED moved +5.14% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $84.53 |
| Market Cap | $10.71B |
| P/E Ratio | 110.28 |
| EPS | $0.76 |
| Dividend Yield | 0.00% |
| 52-Week High | $101.40 |
| 52-Week Low | $51.79 |
| Volume | 2.15M |
| Avg Volume | 0 |
| Revenue (TTM) | $2.52B |
| Net Income | $102.98M |
| Gross Margin | 58.90% |
12 analysts cover GMED: 0 strong buy, 10 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $110.90.